Metabolomic Diagnostics’ CEO, Mr Charles Garvey and VP of R&D, Dr Robin Tuytten, PhD, will attend the 66th Annual Meeting of the Society for Reproductive Investigations (SRI) in Paris, France.
“From Innovation to Impact” is this year’s theme at SRI. It highlights the Society’s dedication to world class innovation in basic research and translational medicine as well as improvements in women’s reproductive health and healthcare.
Metabolomic Diagnostics, together with their clinical collaborators will present a poster entitled:
“Metabolite biomarkers for early prediction of pre-eclampsia in women with obesity”
They discuss their findings where specific metabolites with predictive performance for pre-eclampsia in obese women were identified.
Drop by our stand at the event to hear more about our prognostic assays.
Date: March 12-16th 2019
Place: Palais des Congrès de Paris, Paris, France